Insider Stock Trading

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	#o	#f	T	TVal	Price	Qty	oc	Own	H
2/17/26 15:12	2/17/26	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	12	17	P.m	1,394	6.79	205	50	618	I
2/13/26 16:20	12/11/24	QDEL	Quidelortho Corp		Health	Diagn	In Vitro & In Vivo Diagnostic	6	9	P	1,498	24.82	60	31	256	I
2/12/26 19:49	2/7/25	OCX	Oncocyte Corp	CA	Health	Diagn	In Vitro & In Vivo Diagnostic	4	12	P.dm	20,285	2.43	8,355	44	27,371	D
1/7/26 16:05	1/5/26	NTLA	Intellia Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	2	2	P	2,406	9.62	250	271	342	D
12/4/25 16:11	12/3/25	ICCC	Immucell Corp /De/	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	3	4	P.m	102	5.08	20	16	142	D
11/17/25 13:12	11/17/25	VNRX	Volitionrx Ltd	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	4	17	P.d	750	0.5525	1,357	17	9,158	D
9/19/25 17:26	9/17/25	AWHL	Aspira Women'S Health Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	3	3	P.d	532	0.4500	1,183	30	5,125	I
3/19/25 16:38	3/17/25	ACHV	Achieve Life Sciences, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	2	2	P	57	2.87	20	38	72	D
11/12/24 08:01	11/11/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	1	1	P	308	26.82	12	40	40	D
10/9/24 13:18	9/6/24	NUTX	Cardio Diagnostics Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	2	3	P.a	60	0.2900	207	13	1,853	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person